The labyrinth of interactions of epstein-barr virus-encoded small RNAs

Reviews in Medical Virology

Volumn 24, Issue 1, 2014, Pages 3-14

  Ahmed, Waqar ^a   Khan, Gulfaraz ^a  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

[No Author keywords available]

Indexed keywords

EPSTEIN BARR VIRUS ENCODED SMALL RNA; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN D; L22 PROTEIN; LA ANTIGEN; PROTEIN KINASE R; RETINOIC ACID INDUCIBLE PROTEIN I; TOLL LIKE RECEPTOR 3; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS RNA;

APOPTOSIS; BIOLOGICAL ACTIVITY; CELL PROLIFERATION; CELL TRANSFORMATION; CELLULAR DISTRIBUTION; EXOSOME; INNER EAR; INTERACTIONS WITH RNA; NONHUMAN; PROTEIN SECRETION; REVIEW; RNA STRUCTURE; RNA SYNTHESIS; VIRUS CARCINOGENESIS; VIRUS CELL INTERACTION;

CARCINOGENESIS; CELL PROLIFERATION; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HOST-PATHOGEN INTERACTIONS; HUMANS; RNA, VIRAL;

EID: 84892488474     PISSN: 10529276     EISSN: 10991654     Source Type: Journal    
DOI: 10.1002/rmv.1763     Document Type: Review

References (150)

1. Epstein MA, Achong BG, Barr YM. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 1964; 1: 702-703.
2. Young LS, Rickinson AB. Epstein-Barr virus: 40years on. Nature Reviews Cancer 2004; 4: 757-768.
3. Rickinson AB, Kieff E. Epstein-Barr virus. In Fields Virol, Knipe DM, Howley PM (eds). Walters Kluwer/Lippincott: Philadelphia, USA, 2007; 2655-2700.
4. Miyashita EM, Yang B, Lam KM, Crawford DH, Thorley-Lawson DA. A novel form of Epstein-Barr virus latency in normal B cells in vivo. Cell 1995; 80: 593-601.
5. Roughan JE, Torgbor C, Thorley-Lawson DA. Germinal center B cells latently infected with Epstein-Barr virus proliferate extensively but do not increase in number. Journal of Virology 2010; 84: 1158-1168.
6. Khan G, Miyashita EM, Yang B, Babcock GJ, Thorley-Lawson DA. Is EBV persistence in vivo a model for B cell homeostasis? Immunity 1996; 5: 173-179.
7. Babcock GJ, Decker LL, Volk M, Thorley-Lawson DA. EBV persistence in memory B cells in vivo. Immunity 1998; 9: 395-404.
8. Young L, Alfieri C, Hennessy K, et al. Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. New England Journal of Medicine 1989; 321: 1080-1085.
9. Gottschalk S, Rooney CM, Heslop HE. Post-transplant lymphoproliferative disorders. Annual Review of Medicine 2005; 56: 29-44.
10. Pope JH, Horne MK, Scott W. Transformation of foetal human leukocytes in vitro by filtrates of a human leukaemic cell line containing herpes-like virus. International Journal of Cancer 1968; 3: 857-866.
11. Henderson E, Miller G, Robinson J, Heston L. Efficiency of transformation of lymphocytes by Epstein-Barr virus. Virology 1977; 76: 152-163.
12. Allday MJ, Crawford DH, Griffin BE. Epstein-Barr virus latent gene expression during the initiation of B cell immortalization. Journal of General Virology 1989; 70(Pt 7): 1755-1764.
13. Klein G, Klein E, Kashuba E. Interaction of Epstein-Barr virus (EBV) with human B-lymphocytes. Biochemical and Biophysical Research Communications 2010; 396: 67-73.
14. Pfeffer S, Zavolan M, Grässer FA, et al. Identification of virus-encoded microRNAs. Science 2004; 304: 734-736.
15. Skalsky RL, Corcoran DL, Gottwein E, et al. The viral and cellular microRNA targetome in lymphoblastoid cell lines. PLoS Pathogens 2012; 8: e1002484.
16. Thorley-Lawson DA, Miyashita EM, Khan G. Epstein-Barr virus and the B cell: that's all it takes. Trends in Microbiology 1996; 4: 204-208.
17. Deacon EM, Pallesen G, Niedobitek G, et al. Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells. Journal of Experimental Medicine 1993; 177: 339-349.
18. Niedobitek G, Kremmer E, Herbst H, et al. Immunohistochemical detection of the Epstein-Barr virus-encoded latent membrane protein 2A in Hodgkin's disease and infectious mononucleosis. Blood 1997; 90: 1664-1672.
19. Komano J, Maruo S, Kurozumi K, Oda T, Takada K. Oncogenic role of Epstein-Barr virus-encoded RNAs in Burkitt's lymphoma cell line Akata. Journal of Virology 1999; 73: 9827-9831.
20. Ruf IK, Rhyne PW, Yang C, Cleveland JL, Sample JT. Epstein-Barr virus small RNAs potentiate tumorigenicity of Burkitt lymphoma cells independently of an effect on apoptosis. Journal of Virology 2000; 74: 10223-10228.
21. Repellin CE, Tsimbouri PM, Philbey AW, Wilson JB. Lymphoid hyperplasia and lymphoma in transgenic mice expressing the small non-coding RNA, EBER1 of Epstein-Barr virus. PLoS ONE 2010; 5: e9092.
22. Hayward SD, Kieff ED. Epstein-Barr virus-specific RNA. I. Analysis of viral RNA in cellular extracts and in the polyribosomal fraction of permissive and nonpermissive lymphoblastoid cell lines. Journal of Virology 1976; 18: 518-525.
23. Lerner MR, Andrews NC, Miller G, Steitz JA. Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus. Proceedings of the National Academy of Sciences of the United States of America 1981; 78: 805-809.
24. Arrand JR, Rymo L. Characterization of the major Epstein-Barr virus-specific RNA in Burkitt lymphoma-derived cells. Journal of Virology 1982; 41: 376-389.
25. Glickman JN, Howe JG, Steitz JA. Structural analyses of EBER1 and EBER2 ribonucleoprotein particles present in Epstein-Barr virus-infected cells. Journal of Virology 1988; 62: 902-911.
26. Clarke PA, Schwemmle M, Schickinger J, Hilse K, Clemens MJ. Binding of Epstein-Barr virus small RNA EBER-1 to the double-stranded RNA-activated protein kinase DAI. Nucleic Acids Research 1991; 19: 243-248.
27. Kieff E, Rickinson AB. Epstein-Barr virus and its replication. In Fields Virol, 5th edn, Knipe DM, Howley PM (eds). Walters Kluwer/Lippincott: Philadelphia, USA, 2007; 2603-2654.
28. Rosa MD, Gottlieb E, Lerner MR, Steitz JA. Striking similarities are exhibited by two small Epstein-Barr virus-encoded ribonucleic acids and the adenovirus-associated ribonucleic acids VAI and VAII. Molecular and Cellular Biology 1981; 1: 785-796.
29. Baer R, Bankier AT, Biggin MD, et al. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 1984; 310: 207-211.
30. Howe JG, Shu MD. Epstein-Barr virus small RNA (EBER) genes: unique transcription units that combine RNA polymerase II and III promoter elements. Cell 1989; 57: 825-834.
31. Arrand JR, Young LS, Tugwood JD. Two families of sequences in the small RNA-encoding region of Epstein-Barr virus (EBV) correlate with EBV types A and B. Journal of Virology 1989; 63: 983-986.
32. Yao QY, Tierney RJ, Croom-Carter D, et al. Isolation of intertypic recombinants of Epstein-Barr virus from T-cell-immunocompromised individuals. Journal of Virology 1996; 70: 4895-4903.
33. Howe JG, Shu MD. Isolation and characterization of the genes for two small RNAs of herpesvirus papio and their comparison with Epstein-Barr virus-encoded EBER RNAs. Journal of Virology 1988; 62: 2790-2798.
34. Weiss LM, Chen YY, Liu XF, Shibata D. Epstein-Barr virus and Hodgkin's disease. A correlative in situ hybridization and polymerase chain reaction study. American Journal of Pathology 1991; 139: 1259-1265.
35. Khan G, Coates PJ, Gupta RK, Kangro HO, Slavin G. Presence of Epstein-Barr virus in Hodgkin's disease is not exclusive to Reed-Sternberg cells. American Journal of Pathology 1992; 140: 757-762.
36. Khan G, Coates PJ, Kangro HO, Slavin G. Epstein-Barr virus (EBV) encoded small RNAs: targets for detection by in situ hybridisation with oligonucleotide probes. Journal of Clinical Pathology 1992; 45: 616-620.
37. Schwemmle M, Clemens MJ, Hilse K, et al. Localization of Epstein-Barr virus-encoded RNAs EBER-1 and EBER-2 in interphase and mitotic Burkitt lymphoma cells. Proceedings of the National Academy of Sciences of the United States of America 1992; 89: 10292-10296.
38. Iwakiri D, Zhou L, Samanta M, et al. Epstein-Barr virus (EBV)-encoded small RNA is released from EBV-infected cells and activates signaling from toll-like receptor 3. Journal of Experimental Medicine 2009; 206: 2091-2099.
39. Iwakiri D, Takada K. Role of EBERs in the pathogenesis of EBV infection. Advances in Cancer Research 2010; 107: 119-136.
40. Rymo L. Identification of transcribed regions of Epstein-Barr virus DNA in Burkitt lymphoma-derived cells. Journal of Virology 1979; 32: 8-18.
41. Lee N, Pimienta G, Steitz JA. AUF1/hnRNP D is a novel protein partner of the EBER1 noncoding RNA of Epstein-Barr virus. RNA 2012; 18: 2073-2082.
42. Samanta M, Iwakiri D, Kanda T, Imaizumi T, Takada K. EB virus-encoded RNAs are recognized by RIG-I and activate signaling to induce type I IFN. The EMBO Journal 2006; 25: 4207-4214.
43. Toczyski DP, Steitz JA. EAP, a highly conserved cellular protein associated with Epstein-Barr virus small RNAs (EBERs). The EMBO Journal 1991; 10: 459-466.
44. Toczyski DP, Steitz JA. The cellular RNA-binding protein EAP recognizes a conserved stem-loop in the Epstein-Barr virus small RNA EBER 1. Molecular and Cellular Biology 1993; 13: 703-710.
45. Sharp TV, Schwemmle M, Jeffrey I, et al. Comparative analysis of the regulation of the interferon-inducible protein kinase PKR by Epstein-Barr virus RNAs EBER-1 and EBER-2 and adenovirus VAI RNA. Nucleic Acids Research 1993; 21: 4483-4490.
46. Vuyisich M, Spanggord RJ, Beal PA. The binding site of the RNA-dependent protein kinase (PKR) on EBER1 RNA from Epstein-Barr virus. EMBO Reports 2002; 3: 622-627.
47. Ablasser A, Bauernfeind F, Hartmann G, Latz E, Fitzgerald KA, Hornung V. RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate. Nature Immunology 2009; 10: 1065-1072.
48. Wolin SL, Cedervall T. The La protein. Annual Review of Biochemistry 2002; 71: 375-403.
49. Gottlieb E, Steitz JA. The RNA binding protein La influences both the accuracy and the efficiency of RNA polymerase III transcription in vitro. The EMBO Journal 1989; 8: 841-850.
50. Stefano JE. Purified lupus antigen La recognizes an oligouridylate stretch common to the 3′ termini of RNA polymerase III transcripts. Cell 1984; 36: 145-154.
51. Maraia RJ. La protein and the trafficking of nascent RNA polymerase III transcripts. Journal of Cell Biology 2001; 153: f13-f18.
52. Rinke J, Steitz JA. Precursor molecules of both human 5S ribosomal RNA and transfer RNAs are bound by a cellular protein reactive with anti-La lupus antibodies. Cell 1982; 29: 149-159.
53. Bachmann M, Pfeifer K, Schröder HC, Müller WE. The La antigen shuttles between the nucleus and the cytoplasm in CV-1 cells. Molecular and Cellular Biochemistry 1989; 85: 103-114.
54. Fok V, Friend K, Steitz JA. Epstein-Barr virus noncoding RNAs are confined to the nucleus, whereas their partner, the human La protein, undergoes nucleocytoplasmic shuttling. Journal of Cell Biology 2006; 173: 319-325.
55. Huang M, Ida H, Arima K, et al. La autoantigen translocates to cytoplasm after cleavage during granzyme B-mediated cytotoxicity. Life Sciences 2007; 81: 1461-1466.
56. Meerovitch K, Svitkin YV, Lee HS, et al. La autoantigen enhances and corrects aberrant translation of poliovirus RNA in reticulocyte lysate. Journal of Virology 1993; 67: 3798-3807.
57. Shiroki K, Isoyama T, Kuge S, et al. Intracellular redistribution of truncated La protein produced by poliovirus 3Cpro-mediated cleavage. Journal of Virology 1999; 73: 2193-2200.
58. Boelens WC, Palacios I, Mattaj IW. Nuclear retention of RNA as a mechanism for localization. RNA 1995; 1: 273-283.
59. Xue D, Rubinson DA, Pannone BK, Yoo CJ, Wolin SL. U snRNP assembly in yeast involves the La protein. The EMBO Journal 2000; 19: 1650-1660.
60. Kurilla MG, Cabradilla CD, Holloway BP, Keene JD. Nucleotide sequence and host La protein interactions of rabies virus leader RNA. Journal of Virology 1984; 50: 773-778.
61. Kurilla MG, Keene JD. The leader RNA of vesicular stomatitis virus is bound by a cellular protein reactive with anti-La lupus antibodies. Cell 1983; 34: 837-845.
62. Gottlieb E, Steitz JA. Function of the mammalian La protein: evidence for its action in transcription termination by RNA polymerase III. The EMBO Journal 1989; 8: 851-861.
63. Samanta M, Takada K. Modulation of innate immunity system by Epstein-Barr virus-encoded non-coding RNA and oncogenesis. Cancer Science 2010; 101: 29-35.
64. Clemens MJ, Hershey JW, Hovanessian AC, et al. PKR: proposed nomenclature for the RNA-dependent protein kinase induced by interferon. Journal of Interferon Research 1993; 13: 241.
65. Spanggord RJ, Vuyisich M, Beal PA. Identification of binding sites for both dsRBMs of PKR on kinase-activating and kinase-inhibiting RNA ligands. Biochemistry (Mosc) 2002; 41: 4511-4520.
66. Spanggord RJ, Beal PA. Selective binding by the RNA binding domain of PKR revealed by affinity cleavage. Biochemistry (Mosc) 2001; 40: 4272-4280.
67. Yoneyama M, Suhara W, Fukuhara Y, Fukuda M, Nishida E, Fujita T. Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300. The EMBO Journal 1998; 17: 1087-1095.
68. Trinchieri G. Type I interferon: friend or foe? Journal of Experimental Medicine 2010; 207: 2053-2063.
69. Balachandran S, Roberts PC, Kipperman T, et al. Alpha/beta interferons potentiate virus-induced apoptosis through activation of the FADD/caspase-8 death signaling pathway. Journal of Virology 2000; 74: 1513-1523.
70. Nanbo A, Yoshiyama H, Takada K. Epstein-Barr virus-encoded poly(A)-RNA confers resistance to apoptosis mediated through Fas by blocking the PKR pathway in human epithelial intestine 407 cells. Journal of Virology 2005; 79: 12280-12285.
71. McKenna SA, Lindhout DA, Shimoike T, Aitken CE, Puglisi JD. Viral dsRNA inhibitors prevent self-association and autophosphorylation of PKR. Journal of Molecular Biology 2007; 372: 103-113.
72. Balachandran S, Kim CN, Yeh WC, Mak TW, Bhalla K, Barber GN. Activation of the dsRNA-dependent protein kinase, PKR, induces apoptosis through FADD-mediated death signaling. The EMBO Journal 1998; 17: 6888-6902.
73. Gil J, Esteban M. The interferon-induced protein kinase (PKR), triggers apoptosis through FADD-mediated activation of caspase 8 in a manner independent of Fas and TNF-alpha receptors. Oncogene 2000; 19: 3665-3674.
74. Clemens MJ. Epstein-Barr virus: inhibition of apoptosis as a mechanism of cell transformation. International Journal of Biochemistry & Cell Biology 2006; 38: 164-169.
75. García-Ruiz C, Colell A, Marí M, Morales A, Fernández-Checa JC. Direct effect of ceramide on the mitochondrial electron transport chain leads to generation of reactive oxygen species ROLE OF MITOCHONDRIAL GLUTATHIONE. Journal of Biological Chemistry 1997; 272: 11369-11377.
76. Nakao A, Yoshihama M, Kenmochi N. RPG: the Ribosomal Protein Gene Database. Nucleic Acids Research 2004; 32(Database issue): D168-D170.
77. Odintsova TI, Müller E-C, Ivanov AV, et al. Characterization and analysis of posttranslational modifications of the human large cytoplasmic ribosomal subunit proteins by mass spectrometry and Edman sequencing. Journal of Protein Chemistry 2003; 22: 249-258.
78. Wool IG, Chan YL, Glück A. Structure and evolution of mammalian ribosomal proteins. Biochemistry and Cell Biology 1995; 73: 933-947.
79. Houmani JL, Ruf IK. Clusters of basic amino acids contribute to RNA binding and nucleolar localization of ribosomal protein L22. PLoS ONE 2009; 4: e5306.
80. Le S, Sternglanz R, Greider CW. Identification of two RNA-binding proteins associated with human telomerase RNA. Molecular Biology of the Cell 2000; 11: 999-1010.
81. Liu P, Tarlé SA, Hajra A, et al. Fusion between transcription factor CBF beta/PEBP2 beta and a myosin heavy chain in acute myeloid leukemia. Science 1993; 261: 1041-1044.
82. Nucifora G, Begy CR, Erickson P, Drabkin HA, Rowley JD. The 3;21 translocation in myelodysplasia results in a fusion transcript between the AML1 gene and the gene for EAP, a highly conserved protein associated with the Epstein-Barr virus small RNA EBER 1. Proceedings of the National Academy of Sciences of the United States of America 1993; 90: 7784-7788.
83. Leopardi R, Ward PL, Ogle WO, Roizman B. Association of herpes simplex virus regulatory protein ICP22 with transcriptional complexes containing EAP, ICP4, RNA polymerase II, and viral DNA requires posttranslational modification by the U(L)13 proteinkinase. Journal of Virology 1997; 71: 1133-1139.
84. Wood J, Frederickson RM, Fields S, Patel AH. Hepatitis C virus 3′X region interacts with human ribosomal proteins. Journal of Virology 2001; 75: 1348-1358.
85. Toczyski DP, Matera AG, Ward DC, Steitz JA. The Epstein-Barr virus (EBV) small RNA EBER1 binds and relocalizes ribosomal protein L22 in EBV-infected human B lymphocytes. Proceedings of the National Academy of Sciences of the United States of America 1994; 91: 3463-3467.
86. Gregorovic G, Bosshard R, Karstegl CE, et al. Cellular gene expression that correlates with EBER expression in Epstein-Barr virus-infected lymphoblastoid cell lines. Journal of Virology 2011; 85: 3535-3545.
87. Fok V, Mitton-Fry RM, Grech A, Steitz JA. Multiple domains of EBER 1, an Epstein-Barr virus noncoding RNA, recruit human ribosomal protein L22. RNA 2006; 12: 872-882.
88. Pichlmair A, Schulz O, Tan CP, et al. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science 2006; 314: 997-1001.
89. Cui S, Eisenächer K, Kirchhofer A, et al. The C-terminal regulatory domain is the RNA 5′-triphosphate sensor of RIG-I. Molecular Cell 2008; 29: 169-179.
90. Yoneyama M, Kikuchi M, Natsukawa T, et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nature Immunology 2004; 5: 730-737.
91. Hornung V, Ellegast J, Kim S, et al. 5′-Triphosphate RNA is the ligand for RIG-I. Science 2006; 314: 994-997.
92. Seth RB, Sun L, Ea C-K, Chen ZJ. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 2005; 122: 669-682.
93. Kitagawa N, Goto M, Kurozumi K, et al. Epstein-Barr virus-encoded poly(A)-RNA supports Burkitt's lymphoma growth through interleukin-10 induction. The EMBO Journal 2000; 19: 6742-6750.
94. Iwakiri D, Sheen T-S, Chen J-Y, Huang DP, Takada K. Epstein-Barr virus-encoded small RNA induces insulin-like growth factor 1 and supports growth of nasopharyngeal carcinoma-derived cell lines. Oncogene 2005; 24: 1767-1773.
95. Samanta M, Iwakiri D, Takada K. Epstein-Barr virus-encoded small RNA induces IL-10 through RIG-I-mediated IRF-3 signaling. Oncogene 2008; 27: 4150-4160.
96. Medzhitov R, Preston-Hurlburt P, Janeway CA. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997; 388: 394-397.
97. Rock FL, Hardiman G, Timans JC, Kastelein RA, Bazan JF. A family of human receptors structurally related to Drosophila Toll. Proceedings of the National Academy of Sciences of the United States of America 1998; 95: 588-593.
98. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001; 413: 732-738.
99. Karikó K, Ni H, Capodici J, Lamphier M, Weissman D. mRNA is an endogenous ligand for Toll-like receptor 3. Journal of Biological Chemistry 2004; 279: 12542-12550.
100. Vercammen E, Staal J, Beyaert R. Sensing of viral infection and activation of innate immunity by Toll-like receptor 3. Clinical Microbiology Reviews 2008; 21: 13-25.
101. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006; 124: 783-801.
102. Lee H-K, Dunzendorfer S, Soldau K, Tobias PS. Double-stranded RNA-mediated TLR3 activation is enhanced by CD14. Immunity 2006; 24: 153-163.
103. Takada K. Role of EBER and BARF1 in nasopharyngeal carcinoma (NPC) tumorigenesis. Seminars in Cancer Biology 2012; 22: 162-165.
104. Lu J-Y, Sadri N, Schneider RJ. Endotoxic shock in AUF1 knockout mice mediated by failure to degrade proinflammatory cytokine mRNAs. Genes & Development 2006; 20: 3174-3184.
105. Sadri N, Schneider RJ. Auf1/hnrnpd-deficient mice develop pruritic inflammatory skin disease. Journal of Investigative Dermatology 2009; 129: 657-670.
106. Gratacós FM, Brewer G. The role of AUF1 in regulated mRNA decay. Wiley Interdisciplinary Reviews: RNA 2010; 1: 457-473.
107. Rozovics JM, Chase AJ, Cathcart AL, et al. Picornavirus modification of a host mRNA decay protein. mBio 2012; 3: e00431-12.
108. Chen CY, Shyu AB. AU-rich elements: characterization and importance in mRNA degradation. Trends in Biochemical Sciences 1995; 20: 465-470.
109. Chen L-Y, Lingner J. AUF1/hnRNP D RNA binding protein functions in telomere maintenance. Molecular Cell 2012; 47: 1-2.
110. Loflin P, Chen CY, Shyu AB. Unraveling a cytoplasmic role for hnRNP D in the in vivo mRNA destabilization directed by the AU-rich element. Genes & Development 1999; 13: 1884-1897.
111. Lal A, Mazan-Mamczarz K, Kawai T, Yang X, Martindale JL, Gorospe M. Concurrent versus individual binding of HuR and AUF1 to common labile target mRNAs. The EMBO Journal 2004; 23: 3092-3102.
112. Pant S, Hilton H, Burczynski ME. The multifaceted exosome: biogenesis, role in normal and aberrant cellular function, and frontiers for pharmacological and biomarker opportunities. Biochemical Pharmacology 2012; 83: 1484-1494.
113. Swaminathan S, Tomkinson B, Kieff E. Recombinant Epstein-Barr virus with small RNA (EBER) genes deleted transforms lymphocytes and replicates in vitro. Proceedings of the National Academy of Sciences of the United States of America 1991; 88: 1546-1550.
114. Laing KG, Elia A, Jeffrey I, et al. In vivo effects of the Epstein-Barr virus small RNA EBER-1 on protein synthesis and cell growth regulation. Virology 2002; 297: 253-269.
115. Iwakiri D, Eizuru Y, Tokunaga M, Takada K. Autocrine growth of Epstein-Barr virus-positive gastric carcinoma cells mediated by an Epstein-Barr virus-encoded small RNA. Cancer Research 2003; 63: 7062-7067.
116. Yang L, Aozasa K, Oshimi K, Takada K. Epstein-Barr virus (EBV)-encoded RNA promotes growth of EBV-infected T cells through interleukin-9 induction. Cancer Research 2004; 64: 5332-5337.
117. Yajima M, Kanda T, Takada K. Critical role of Epstein-Barr virus (EBV)-encoded RNA in efficient EBV-induced B-lymphocyte growth transformation. Journal of Virology 2005; 79: 4298-4307.
118. Nanbo A, Inoue K, Adachi-Takasawa K, Takada K. Epstein-Barr virus RNA confers resistance to interferon-alpha-induced apoptosis in Burkitt's lymphoma. The EMBO Journal 2002; 21: 954-965.
119. Ruf IK, Lackey KA, Warudkar S, Sample JT. Protection from interferon-induced apoptosis by Epstein-Barr virus small RNAs is not mediated by inhibition of PKR. Journal of Virology 2005; 79: 14562-14569.
120. Wong HL, Wang X, Chang RC-C, et al. Stable expression of EBERs in immortalized nasopharyngeal epithelial cells confers resistance to apoptotic stress. Molecular Carcinogenesis 2005; 44: 92-101.
121. Yamamoto N, Takizawa T, Iwanaga Y, Shimizu N, Yamamoto N. Malignant transformation of B lymphoma cell line BJAB by Epstein-Barr virus-encoded small RNAs. FEBS Letters 2000; 484: 153-158.
122. Masood R, Zhang Y, Bond MW, et al. Interleukin-10 is an autocrine growth factor for acquired immunodeficiency syndrome-related B-cell lymphoma. Blood 1995; 85: 3423-3430.
123. Yoshizaki T, Endo K, Ren Q, et al. Oncogenic role of Epstein-Barr virus-encoded small RNAs (EBERs) in nasopharyngeal carcinoma. Auris, Nasus, Larynx 2007; 34: 73-78.
124. Tsang CM, Zhang G, Seto E, et al. Epstein-Barr virus infection in immortalized nasopharyngeal epithelial cells: regulation of infection and phenotypic characterization. International Journal of Cancer 2010; 127: 1570-1583.
125. Clemens MJ. PKR-a protein kinase regulated by double-stranded RNA. International Journal of Biochemistry & Cell Biology 1997; 29: 945-949.
126. Komano J, Sugiura M, Takada K. Epstein-Barr virus contributes to the malignant phenotype and to apoptosis resistance in Burkitt's lymphoma cell line Akata. Journal of Virology 1998; 72: 9150-9156.
127. Daker M, Bhuvanendran S, Ahmad M, Takada K, Khoo AS-B. Deregulation of lipid metabolism pathway genes in nasopharyngeal carcinoma cells. Molecular Medicine Reports 2013; 7: 731-741.
128. Eilebrecht S, Pellay F-X, Odenwälder P, Brysbaert G, Benecke B-J, Benecke A. EBER2 RNA-induced transcriptome changes identify cellular processes likely targeted during Epstein-Barr virus infection. BMC Research Notes 2008; 1: 100.
129. Wu Y, Maruo S, Yajima M, Kanda T, Takada K. Epstein-Barr virus (EBV)-encoded RNA 2 (EBER2) but not EBER1 plays a critical role in EBV-induced B-cell growth transformation. Journal of Virology 2007; 81: 11236-11245.
130. Raposo G, Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. Journal of Cell Biology 2013; 200: 373-383.
131. Trams EG, Lauter CJ, Salem N Jr, Heine U. Exfoliation of membrane ecto-enzymes in the form of micro-vesicles. Biochimica et Biophysica Acta 1981; 645: 63-70.
132. Izquierdo-Useros N, Naranjo-Gomez M, Erkizia I, et al. HIV and mature dendritic cells: Trojan exosomes riding the Trojan horse? PLoS Pathogens 2010; 6: e1000740.
133. Kadiu I, Narayanasamy P, Dash PK, Zhang W, Gendelman HE. Biochemical and biologic characterization of exosomes and microvesicles as facilitators of HIV-1 infection in macrophages. Journal of immunology (Baltimore, Md.: 1950) 2012; 189: 744-754.
134. Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nature Cell Biology 2007; 9: 654-659.
135. Balaj L, Lessard R, Dai L, et al. Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences. Nature Communications 2011; 2: 180.
136. Cocucci E, Racchetti G, Meldolesi J. Shedding microvesicles: artefacts no more. Trends in Cell Biology 2009; 19: 43-51.
137. Andaloussi SE, Mäger I, Breakefield XO, Wood MJA. Extracellular vesicles: biology and emerging therapeutic opportunities. Nature Reviews Drug Discovery 2013; 12: 347-357.
138. Février B, Raposo G. Exosomes: endosomal-derived vesicles shipping extracellular messages. Current Opinion in Cell Biology 2004; 16: 415-421.
139. Piper RC, Katzmann DJ. Biogenesis and function of multivesicular bodies. Annual Review of Cell and Developmental Biology 2007; 23: 519-547.
140. Koppers-Lalic D, Hogenboom MM, Middeldorp JM, Pegtel DM. Virus-modified exosomes for targeted RNA delivery; a new approach in nanomedicine. Advanced Drug Delivery Reviews 2013; 65: 348-356.
141. Mack M, Kleinschmidt A, Brühl H, et al. Transfer of the Chemokine receptor CCR5 between cells by membrane-derived microparticles: a mechanism for cellular human immunodeficiency virus 1 infection. Nature Medicine 2000; 6: 769-775.
142. Pegtel DM, Cosmopoulos K, Thorley-Lawson DA, et al. Functional delivery of viral miRNAs via exosomes. Proceedings of the National Academy of Sciences of the United States of America 2010; 107: 6328-6333.
143. Bachmann M, Chang S, Slor H, Kukulies J, Müller WE. Shuttling of the autoantigen La between nucleus and cell surface after uv irradiation of human keratinocytes. Experimental Cell Research 1990; 191: 171-180.
144. Ayukawa K, Taniguchi S, Masumoto J, et al. La autoantigen is cleaved in the COOH terminus and loses the nuclear localization signal during apoptosis. Journal of Biological Chemistry 2000; 275: 34465-34470.
145. Bachmann M, Althoff H, Tröster H, Selenka C, Falke D, Müller WE. Translocation of the nuclear autoantigen La to the cell surface of herpes simplex virus type 1 infected cells. Autoimmunity 1992; 12: 37-45.
146. Kapsogeorgou EK, Abu-Helu RF, Moutsopoulos HM, Manoussakis MN. Salivary gland epithelial cell exosomes: a source of autoantigenic ribonucleoproteins. Arthritis and Rheumatism 2005; 52: 1517-1521.
147. Lotvall J, Valadi H. Cell to cell signalling via exosomes through esRNA. Cell Adhesion & Migration 2007; 1: 156-158.
148. Mittelbrunn M, Sánchez-Madrid F. Intercellular communication: diverse structures for exchange of genetic information. Nature Reviews Molecular Cell Biology 2012; 13: 328-335.
149. Regev-Rudzki N, Wilson DW, Carvalho TG, et al. Cell-cell communication between malaria-infected red blood cells via exosome-like vesicles. Cell 2013; 153: 1120-1133.
150. Skog J, Würdinger T, van Rijn S, et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nature Cell Biology 2008; 10: 1470-1476.